在模型中多模式分析败血症诱导的心肌病
bioRxiv : the preprint server for biology
|July 16, 2025
概括
败血症引起的心肌病 (SIC) 涉及炎症和线粒体功能障碍,导致不良结果. 幸存者表现出修复路径,而非幸存者在这个灵长类模型中表现出不适应的重塑.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 败血症引起的心肌病 (SIC) 是败血症患者的主要死亡原因.
- 了解SIC机制对于开发有效的治疗方法至关重要.
研究的目的:
- 用非人类灵长类动物模型来描述败血症诱导心肌病的分子和功能变化.
- 为了确定败血症幸存者和非幸存者之间的转录组形状的差异.
主要方法:
- 采用了一种多模式的方法,包括单核RNA测序 (snRNA-seq),心声学,线粒体功能检测和组织病理学.
- 分析了档案数据和来自的样本,这些被挑战了peptidoglycan.
- 监测生命体征和心脏功能,终点包括生存或安乐死.
主要成果:
- 败血性休克与心脏输出减少和生存率低下有关.
- snRNA-seq揭示了不同的转录组特征:非幸存者表现出炎症和线粒体功能障碍,而幸存者则激活了修复途径.
- 心肌细胞显示代谢功能障碍,内皮细胞显示TNF/NF-κB驱动的炎症,纤维细胞/细胞显示应激反应.
结论:
- 这种非人类灵长类动物模型有效地回顾了败血症诱导心肌病的关键特征.
- 这些发现突出了明显的细胞和分子机制,使幸存者与非幸存者区分开来.
- 这项研究为进一步对SIC.的机制和治疗研究提供了基础.
相关概念视频
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...


